163 related articles for article (PubMed ID: 25219651)
1. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.
Luo S; Tsao H
J Invest Dermatol; 2014 Oct; 134(10):2493-2496. PubMed ID: 25219651
[TBL] [Abstract][Full Text] [Related]
2. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
Gerami P; Paller AS
J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing of nevus spilus-type congenital melanocytic nevus: exquisite genotype-phenotype correlation in mosaic RASopathies.
Kinsler VA; Krengel S; Riviere JB; Waelchli R; Chapusot C; Al-Olabi L; Faivre L; Haenssle HA; Weibel L; Jeudy G; Vabres P
J Invest Dermatol; 2014 Oct; 134(10):2658-2660. PubMed ID: 24751729
[No Abstract] [Full Text] [Related]
4. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
[TBL] [Abstract][Full Text] [Related]
5. Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets.
Ramesh R; Shaw N; Miles EK; Richard B; Colmenero I; Moss C
Clin Exp Dermatol; 2017 Jan; 42(1):75-79. PubMed ID: 27900779
[TBL] [Abstract][Full Text] [Related]
6. Mosaic NRASopathy n a child with giant melanocytic congenital naevus, epidermal hamartoma and bilateral nephroblastomatosis: clinical implication for follow-up.
Maridet C; Morice-Picard F; Gros A; Crivelli L; de la Fouchardière A; Vergier B; Taïeb A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e258-e260. PubMed ID: 29314428
[No Abstract] [Full Text] [Related]
7. Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations.
Stark MS
J Invest Dermatol; 2019 Apr; 139(4):756-759. PubMed ID: 30904080
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
9. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
10. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
[TBL] [Abstract][Full Text] [Related]
11. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.
Charbel C; Fontaine RH; Malouf GG; Picard A; Kadlub N; El-Murr N; How-Kit A; Su X; Coulomb-L'Hermine A; Tost J; Mourah S; Aractingi S; Guégan S
J Invest Dermatol; 2014 Apr; 134(4):1067-1074. PubMed ID: 24129063
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Melanocytic Tumors With Concomitant NRASQ61R and IDH1R132C Mutations: A Report of 6 Cases.
Macagno N; Pissaloux D; Etchevers H; Haddad V; Vergier B; Sierra-Fortuny S; Tirode F; de la Fouchardière A
Am J Surg Pathol; 2020 Oct; 44(10):1398-1405. PubMed ID: 32732488
[TBL] [Abstract][Full Text] [Related]
13. Melanoma arising in a giant congenital melanocytic nevus with neuroblastoma RAS mutation.
Dudani P; Senthilnathan G; Wajid MA; Gupta AK; Kaushal S; Arora S; Shamim SA; Bhari N
Indian J Dermatol Venereol Leprol; 2021; 87(3):416-420. PubMed ID: 33871206
[No Abstract] [Full Text] [Related]
14. The Distinctive Genomic Landscape of Giant Congenital Melanocytic Nevi.
Stark MS; Tell-Martí G; Martins da Silva V; Martinez-Barrios E; Calbet-Llopart N; Vicente A; Sturm RA; Soyer HP; Puig S; Malvehy J; Carrera C; Puig-Butillé JA
J Invest Dermatol; 2021 Mar; 141(3):692-695.e2. PubMed ID: 32800874
[No Abstract] [Full Text] [Related]
15. Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi.
Etchevers HC
J Invest Dermatol; 2014 Apr; 134(4):879-882. PubMed ID: 24646799
[TBL] [Abstract][Full Text] [Related]
16. Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings.
McGrath LA; Palmer JM; Stark A; Glasson W; Warrier SK; Whitehead K; Hamilton H; Brooks K; Johansson PA; Hayward NK
Ophthalmic Genet; 2020 Dec; 41(6):616-620. PubMed ID: 32814477
[TBL] [Abstract][Full Text] [Related]
17. SCALP syndrome with a germline heterozygous DOCK6 mutation and somatic mosaic NRAS Q61R mutation.
Meyer SN; Simmons EM; McPherson JD; Awasthi S; Kiuru M
Pediatr Dermatol; 2023; 40(3):523-527. PubMed ID: 36456540
[TBL] [Abstract][Full Text] [Related]
18. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
19. Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
Krengel S; Widmer DS; Kerl K; Levesque MP; Schiestl C; Weibel L
Br J Dermatol; 2016 Mar; 174(3):642-4. PubMed ID: 26302237
[No Abstract] [Full Text] [Related]
20. Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome.
Carli D; Cardaropoli S; Tessaris D; Coppo P; La Selva R; Cesario C; Lepri FR; Pullano V; Palumbo M; Ramenghi U; Brusco A; Medico E; De Sanctis L; Ferrero GB; Mussa A
Genes Chromosomes Cancer; 2022 Dec; 61(12):740-746. PubMed ID: 35999193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
